January 20, 2025 MabPlex Facilitates Commercialization of Teruisi’s TRS005 Program with Successful Execution of PPQ Milestone
January 18, 2024 MabPlex passed the EU QP on-site audit again, supporting U.S. client in conducting transatlantic clinical trials
